Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Valsartan vs Irbesartan in Hemodialysis Patients (VALID)
NCT00171080Phase 3Completed
- Sponsor
- Novartis
- Start
- Apr 2004
- Primary completion
- Mar 2006
- Modality
- Small Molecules
- Countries
- 2
01
Overview
Phase 3, randomised, open-label trial of valsartan in hypertension (HTN) (2 arms), sponsored by Novartis. Primary endpoint: Change from baseline in systolic blood pressure at 4 weeks. Started Apr 2004; status: completed.
02
Drugs
valsartan
03
Conditions
hypertension (HTN)
Beyond the preview
Go deeper on NCT00171080.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00171080.